A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia
NCT02561598 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-12-15
Summary
The purpose of the study is to develop methods to identify predictors of Malignant Hyperthermia.
Conditions
- Malignant Hyperthermia
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
John McAuliffe, MD · Children's Hospital Medical Center, Cincinnati
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-31
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Specialty Queue For Gestational Trophoblastic Neoplasia
NCT06681259 ·Status: RECRUITING
-
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
NCT03630536 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
NCT00918658 ·Status: TERMINATED
-
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
NCT01623856 ·Status: COMPLETED
-
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
NCT00001503 ·Status: COMPLETED
-
Genetic Variants and Chemotherapy-induced Abnormal Thermal Sensation
NCT03252834 ·Status: TERMINATED
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
NCT00898079 ·Status: COMPLETED
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00898742 ·Status: TERMINATED
-
A Gene Hunting Study for Familial Papillary Thyroid Cancer
NCT02776969 ·Status: ACTIVE_NOT_RECRUITING
-
The Pathogenesis and Prognostic Factors of Lymphoma
NCT06203652 ·Status: RECRUITING
-
Study of Specimens From Young Patients With Neuroblastoma
NCT00958659 ·Status: COMPLETED
-
Cancer in Infants: South Egypt Cancer Institute Experience
NCT02668354 ·Status: UNKNOWN
-
Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls
NCT01312506 ·Status: WITHDRAWN
-
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT05710679 ·Status: RECRUITING ·Phase: NA
-
Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study
NCT00322790 ·Status: WITHDRAWN
-
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
NCT00436696 ·Status: COMPLETED
-
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
NCT00918008 ·Status: TERMINATED
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
Mitochondrial Respiratory Function in Mammalian Skeletal Muscle
NCT02650570 ·Status: TERMINATED
-
PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
NCT00530283 ·Status: COMPLETED
-
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
NCT01325142 ·Status: COMPLETED
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED